Part of Cancer staging guidance sheets
Neuroblastoma
Introduction
This is the data sheet for TNM 8th edition staging of neuroblastoma
International neuroblastoma risk group
|
Stage |
Description |
|---|---|
|
L1 |
Localised tumour not involving vital structures as defined by the list of image-defined risk factors and confined to one body compartment |
|
L2 |
Locoregional tumour with presence of one or more image-defined risk factors |
|
M |
Distant metastatic disease (except stage MS) |
|
MS |
Metastatic disease in children younger than 18 months with metastases confined to skin, liver, and/or bone marrow |
Image-defined risk factors (IDRFS) in neuroblastic tumours
|
Ipsilateral tumour extension within two body compartments |
Neck-chest, chest-abdomen, abdomen-pelvis |
|---|---|
|
Neck |
Tumour encasing carotid and/or vertebral artery and/or internal jugular vein Tumour extending to base of skull Tumour compressing the trachea |
|
Cervico-thoracic junction |
Tumour encasing brachial plexus roots Tumour encasing subclavian vessels and/or vertebral and/or carotid artery Tumour compressing the trachea |
|
Thorax |
Tumour encasing the aorta and/or major branches Tumour compressing the trachea and/or principal bronchi Lower mediastinal tumour, infiltrating the costo-vertebral junction between T9 and T12 |
|
Thoraco-abdominal |
Tumour encasing the aorta and/or vena cava |
|
Abdomen/pelvis |
Tumour infiltrating the porta hepatis and/or the hepatoduodenal ligament Tumour encasing branches of the superior mesenteric artery at the mesenteric root Tumour encasing the origin of the coeliac axis, and/or of the superior mesenteric artery Tumour invading one or both renal pedicles Tumour encasing the aorta and/or vena cava Tumour encasing the iliac vessels Pelvic tumour crossing the sciatic notch |
|
Intraspinal tumour extension whatever the location provided that: |
More than one third of the spinal canal in the axial plane is invaded and/or the perimedullary leptomeningeal spaces are not visible and/or the spinal cord signal is abnormal |
|
Infiltration of adjacent organs/structures |
Pericardium, diaphragm, kidney, liver, duodeno-pancreatic block, and mesentery |
|
Conditions to be recorded, but not considered IDRFs |
Multifocal primary tumours Pleural effusion, with or without malignant cells Ascites, with or without malignant cells |
Download
Click on the box below to download a PDF version of this data sheet:
Last edited: 14 June 2023 2:12 pm
- Cancer staging guidance sheets
- Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
- Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
- Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
- Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
- Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
- Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
- Stomach (ICD10 C16 - excluding C16.0)
- Small intestine (ICD10 C17)
- Appendix (ICD10 C18.1)
- Colon and rectum (ICD10 C18-C20)
- Anal and perianal skin (ICD10 C21)
- Liver (ICD10 C22.0)
- Intrahepatic bile ducts (ICD10 C22.1)
- Gallbladder (ICD10 C23)
- Distal extrahepatic bile duct (ICD10 C24.0)
- Perihilar bile ducts (ICD10 C24.0)
- Ampulla of vater (ICD10 C24.1)
- Pancreas (ICD10 C25)
- Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
- Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
- Lung (ICD10 C34)
- Thymus tumours (ICD10 C37.9)
- Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
- Bone (ICD10 C40, C41)
- Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
- Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
- Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
- Carcinoma of skin of the eyelid (ICD10 C44.1)
- Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
- Pleural mesothelioma (ICD10 C38.4)
- Breast tumours (ICD10 C50)
- Vulva (ICD10 C51)
- Cervix uteri (ICD10 C53)
- Uterine sarcomas
- Uterus - endometrium (ICD10 C54.1, C55)
- Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
- Gestational trophoblastic neoplasms (ICD10 C58)
- Penis tumours (ICD10 C60)
- Prostate tumours (ICD10 C61.9)
- Testis tumours (ICD10 C62)
- Kidney tumours (ICD10 C64)
- Renal pelvis and ureter tumours (ICD10 C65 & C66)
- Urinary bladder tumours (ICD10 C67)
- Urethra tumours (ICD10 C68.0, C61.9)
- Carcinoma of conjuctiva (ICD10 C69.0)
- Melanoma of conjuctiva (ICD10 C69.0)
- Retinoblastoma (ICD10 C69.2)
- Melanoma of uvea (ICD10 C69.3-4)
- Carcinoma of lacrimal gland (ICD10 C69.5)
- Sarcoma of orbit (ICD10 C69.6)
- Thyroid gland (ICD10 C73.9)
- Adrenal cortex (ICD10 C74.0)
- Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
- Parathyroid gland (ICD10 C75.0)
- Unknown primary - cervical nodes (ICD10 C77.0)
- Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
- T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
- Rhabdomyosarcoma (CTYA)
- Chronic lymphocytic leukaemia
- Hepatoblastoma (CTYA)
- Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
- Medulloblastoma
- Multiple myeloma
- Neuroblastoma
- Neuroendocrine tumours of the foregut
- Neuroendocrine tumours of the midgut and hindgut
- Non-hodgkin lymphoma (children)
- Wilms tumour of the kidney